Ind-Swift Laboratories Limited (BOM:532305)
India · Delayed Price · Currency is INR 110.67
+3.10 (2.88%)
At close: Sep 10, 2025
Ind-Swift Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 5,674 | 5,617 | 12,809 | 12,073 | 10,387 | 8,913 | Upgrade |
Other Revenue | - | - | 163.66 | 86.24 | 141.74 | 154.32 | Upgrade |
| 5,674 | 5,617 | 12,973 | 12,159 | 10,529 | 9,068 | Upgrade | |
Revenue Growth (YoY) | -43.47% | -56.70% | 6.69% | 15.48% | 16.11% | 13.44% | Upgrade |
Cost of Revenue | 2,700 | 2,880 | 6,615 | 6,556 | 5,374 | 4,514 | Upgrade |
Gross Profit | 2,974 | 2,738 | 6,358 | 5,604 | 5,155 | 4,553 | Upgrade |
Selling, General & Admin | 1,224 | 1,175 | 1,582 | 1,401 | 1,278 | 1,079 | Upgrade |
Other Operating Expenses | 1,844 | 1,756 | 2,092 | 1,814 | 1,642 | 1,492 | Upgrade |
Operating Expenses | 3,323 | 3,176 | 4,208 | 3,788 | 4,231 | 3,444 | Upgrade |
Operating Income | -348.44 | -438.69 | 2,150 | 1,815 | 924.23 | 1,110 | Upgrade |
Interest Expense | - | -29.19 | -466.94 | -863.93 | -914.53 | -933.53 | Upgrade |
Interest & Investment Income | 56.41 | - | 183.71 | 58.72 | 5.62 | 5.13 | Upgrade |
Earnings From Equity Investments | 1.48 | -0.52 | -4.9 | -2.34 | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | 105.52 | 180.87 | 147.63 | 32.72 | Upgrade |
Other Non Operating Income (Expenses) | 528.94 | 813.82 | -43.32 | -48.57 | 99.03 | -33.83 | Upgrade |
EBT Excluding Unusual Items | 238.39 | 345.43 | 1,924 | 1,140 | 261.99 | 180.09 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 22.35 | -0.61 | -65.66 | - | Upgrade |
Asset Writedown | - | - | - | -10 | -71.01 | - | Upgrade |
Other Unusual Items | 2,152 | 2,232 | 3,866 | -266.48 | - | - | Upgrade |
Pretax Income | 2,391 | 2,577 | 5,813 | 862.87 | 125.33 | 180.09 | Upgrade |
Income Tax Expense | 90.05 | 72.7 | 1,603 | 386.9 | 146.82 | 211.56 | Upgrade |
Net Income | 2,301 | 2,505 | 4,210 | 475.97 | -21.49 | -31.47 | Upgrade |
Net Income to Common | 2,301 | 2,505 | 4,210 | 475.97 | -21.49 | -31.47 | Upgrade |
Net Income Growth | -43.14% | -40.50% | 784.44% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 68 | 67 | 59 | 59 | 59 | 59 | Upgrade |
Shares Outstanding (Diluted) | 73 | 71 | 59 | 59 | 59 | 59 | Upgrade |
Shares Change (YoY) | 23.98% | 20.39% | - | - | - | 19.46% | Upgrade |
EPS (Basic) | 34.05 | 37.25 | 71.24 | 8.06 | -0.36 | -0.53 | Upgrade |
EPS (Diluted) | 31.48 | 35.21 | 71.24 | 8.06 | -0.36 | -0.53 | Upgrade |
EPS Growth | -54.14% | -50.58% | 784.38% | - | - | - | Upgrade |
Free Cash Flow | - | -898.8 | -2,076 | 1,818 | 1,319 | 1,310 | Upgrade |
Free Cash Flow Per Share | - | -12.63 | -35.14 | 30.78 | 22.32 | 22.18 | Upgrade |
Gross Margin | 52.41% | 48.74% | 49.01% | 46.08% | 48.96% | 50.21% | Upgrade |
Operating Margin | -6.14% | -7.81% | 16.58% | 14.93% | 8.78% | 12.24% | Upgrade |
Profit Margin | 40.55% | 44.59% | 32.45% | 3.91% | -0.20% | -0.35% | Upgrade |
Free Cash Flow Margin | - | -16.00% | -16.00% | 14.95% | 12.52% | 14.45% | Upgrade |
EBITDA | -175.65 | -193.89 | 2,683 | 2,389 | 2,235 | 1,983 | Upgrade |
EBITDA Margin | -3.09% | -3.45% | 20.68% | 19.64% | 21.22% | 21.86% | Upgrade |
D&A For EBITDA | 172.79 | 244.79 | 532.8 | 573.39 | 1,310 | 872.92 | Upgrade |
EBIT | -348.44 | -438.69 | 2,150 | 1,815 | 924.23 | 1,110 | Upgrade |
EBIT Margin | -6.14% | -7.81% | 16.58% | 14.93% | 8.78% | 12.24% | Upgrade |
Effective Tax Rate | 3.77% | 2.82% | 27.58% | 44.84% | 117.15% | 117.48% | Upgrade |
Revenue as Reported | 6,203 | 6,431 | 13,263 | 12,408 | 10,822 | 9,140 | Upgrade |
Advertising Expenses | - | - | 45.55 | 34.92 | 2.36 | 7.66 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.